Biotech InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation November 21, 2024
Biotech Thryv Therapeutics Announces the Appointment of Esteemed Executive Leader Amy Sehnert, MD, as Chief Medical Officer November 20, 2024
Biotech Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain November 19, 2024
Biotech Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE November 18, 2024
Biotech BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 November 17, 2024
Biotech Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial November 14, 2024
Biotech Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates November 13, 2024
Biotech Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand November 12, 2024
Search
Biotech
November 21, 2024
November 20, 2024
November 19, 2024
November 18, 2024
November 17, 2024
November 16, 2024
November 15, 2024
November 14, 2024
November 13, 2024
November 12, 2024
